We may be able to help insured patients pay their out-of-pocket costs for prescribed Bristol-Myers Squibb medicines.

Medicine of Interest:

• BARACLUDE® (entecavir)
• ERBITUX® (cetuximab)
• IXEMPRA® (ixabepilone)
• KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release)
• NULOJIX® (belatacept)
• ONGLYZA® (saxagliptin)
• ORENCIA® (abatacept)
• REYATAZ® (atazanavir sulfate)
• SPRYCEL® (dasatinib)
• SUSTIVA® (efavirenz)
• YERVOY® (ipilimumab)

Please click on product name listed here to see the Full U.S. Prescribing Information for BARACLUDE®, ERBITUX®, IXEMPRA®, KOMBIGLYZE™, NULOJIX®, ONGLYZA®, ORENCIA®, REYATAZ®, SPRYCEL®, SUSTIVA®, and YERVOY®, including Boxed WARNINGS for BARACLUDE®, IXEMPRA®, KOMBIGLYZE™, NULOJIX®, ONGLYZA®, and Boxed WARNING for YERVOY® regarding immune-mediated adverse reactions and Boxed WARNINGS for ERBITUX® regarding infusion reactions and cardiopulmonary arrest.